Table 5.
Distribution of KIR haplotypes and their associations with RA.
| Haplotype | Included genes | Frequency in cases | Frequency in controls | Odds ratio | 95% CI | p-value | p-value (Yate's correction) |
|---|---|---|---|---|---|---|---|
| Centromeric A | 2DL3 | 37 (74%) | 88 (88%) | 0.388 | 0.183-0.822 | 0.0301* | 0.0528 |
| 2DL1 | |||||||
| Centromeric B | 2DS2 | 30 (60%) | 54 (54%) | 1.278 | 0.729-2.239 | 0.4853 | 0.6007 |
| 2DL2 | |||||||
| 2DS3 | |||||||
| 2DL5 | |||||||
| 2DL1 | |||||||
| Telomeric A | 3DL1 | 46 (92%) | 96 (96%) | 0.479 | 0.139-1.646 | 0.3041 | 0.5206 |
| 2DS4 | |||||||
| Telomeric B | 3DS1 | 24 (48%) | 45 (45%) | 1.128 | 0.647-1.967 | 0.7282 | 0.8621 |
| 2DL5 | |||||||
| 3DS3 | |||||||
| 2DS1 | |||||||
| 2DS5 |
*
Significant at 0.05.